Alvarez & Marsal Managing Director Mark Freitas was featured among Top 25 Life Sciences Consultants and Leaders of 2024
The Consulting Report is pleased to announce The Top 25 Life Sciences Consultants and Leaders of 2024. The life sciences industry has undergone significant transformation in recent years, fueled by scientific breakthroughs, technological innovation, and the global impact of the COVID-19 pandemic. While these shifts have ushered in new opportunities for patient care, drug development, and medical innovation, they have also presented complex challenges. Life sciences organizations now face increased pressure to optimize pricing, navigate unpredictable market access, adapt to changing consumer behavior, and enhance operational efficiency.
Mark Freitas specializes in helping businesses reach their full potential by developing successful strategies that maximize growth while avoiding operational challenges. His expertise spans corporate finance and operations, strategic planning, board governance, mergers and acquisitions activity, risk management, and compliance.
Read the Full Article Here
Navigating Global Pharma Policy
November 4, 2025
As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could be felt across the global healthcare landscape. For an industry already grappling with rising R&D costs and competitive pressures, these tariffs threaten to erode profit margins and disrupt finely tuned supply chains.
CRLs Unveiled: Converting FDA Transparency into a Market Advantage
October 27, 2025
With the FDA’s disclosure of 200 Complete Response Letters (CRLs), leadership teams now have an unprecedented insight into regulatory decision-making to glean patterns, challenge assumptions, and strengthen governance before avoidable failures occur.
What if the biosimilar wave is just a ripple?
September 9, 2025
As biologics face a record-breaking patent cliff, the anticipated biosimilar wave may be more of a ripple than a wave. To thrive, life sciences firms must shift from solely pursuing speed to mastering precision.
ALVAREZ & MARSAL BOLSTERS ITS HEALTHCARE PRACTICE IN SOUTHEAST ASIA (ASEAN) REGION WITH THE APPOINTMENT OF SANATH KUMAR AS MANAGING DIRECTOR
September 1, 2025
Leading global professional services firm Alvarez & Marsal (A&M) has announced the appointment of Sanath Kumar as Managing Director within its Southeast Asia and Australia (SEAA) business unit. Based in Singapore, Mr. Sanath will play a strategic role in building out A&M’s Healthcare and Life Sciences practice across ASEAN markets.
